| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0059 | 0.9 |